No Detail Found!

Pakistan's perspective on COVID-19 vaccines

Author(s)
Taimoor Hassan School of Pharmacy & School of Medicine, Changzhou University, Jiangsu, China; Department of Anthropology, Quaid-e-Azam University, Islamabad, Pakistan
Saleha Saleha Department of Health Professional Technologies, The University of Lahore, Pakistan
Abstract
There has never been a pandemic of this magnitude in contemporary human history. In less than 16 months after the outbreak of the pandemic, almost 188 million confirmed COVID-19 cases and 2.5 million fatalities have been reported globally. In addition, a great deal of work has been done to discover vaccinations that are both safe and effective. In May 2021, 184 SARS-Cov-2 vaccine contestants were in pre-clinical trials, 105 were in clinical trials, and 18 vaccines had been licensed for emergency use by at least one national or international regulatory body. Till date, only 5 vaccines are given approval by WHO for emergency use that includes, Pfizer-BioNTech, Moderna, AstraZeneca, Sinopharm, Johnson & Johnson. These vaccines include entire virus inactivated or live attenuated, virus vector, protein-based, and nucleic acid vaccines. Currently, confusing information about the COVID-19 vaccination is being disseminated across the world. During health emergency, rumors spread and caused panic, insanity, and anxiety. SARS-CoV-2 strains, on the other hand, are constantly appearing over the world. This article provides a Pakistan's perspective towards COVID-19 vaccines with an updated review.
Publication Details
Page(s) 111-116
Published Journal: Gomal Journal of Medical Sciences, Volume: 19, Issue: 3, Year: 2021

Request the full text from PASTIC

Keywords
COVID-19, National Perspective, COVID-19 Vaccines, Therapeutic Misconception, Conspiracy Theories
0

Citations

0

Downloads

48

Views